In this episode of Heliograph, host Blair Bigham sits down with world-famous bioethicist Dr. Arthur Caplan to pull back the curtain on the shadowy world of phase one clinical trials, where new drugs are tested on humans for the first time in a broken system of incentives and lies.

The IJB had the pleasure of speaking with the professor from his office at NYU Langone in New York City. Caplan, the founding head of the Division of Medical Ethics at the NYU Grossman School of Medicine’s Department of Population Health, dives deep into the ethics of recruitment techniques used by Contract Research Organizations (CROs) and discusses ways technology, such as AI, can help CROs prevent trial participants from 'double-dipping' in multiple trials, contaminating both their bodies and the trial results.

Stay up to date with IJB investigations, podcasts and events by subscribing to the newsletter here

Learn more about IJB at: ijb.utoronto.ca

Support the IJB at: https://ijb.utoronto.ca/support-us/

Hosted on Acast. See acast.com/privacy for more information.